Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Pariser

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Journal of the American Academy of Dermatology|August 1, 1994
Double-blind comparison of itraconazole and placebo in the treatment of tinea corporis and tinea crurisD M Pariser, R J Pariser, G Ruoff, et al.
The British Journal of Dermatology|December 15, 2015
Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled studyD M Pariser, L F Eichenfield, M Bukhalo, et al.
Archives of Dermatology|August 1, 1976
Intravenous desensitization to mechlorethamine in patients with psoriasisD M Pariser, R C Childers, P Kechijian, et al.
The British Journal of Dermatology|November 17, 2006
Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow upE H Tschen, D S Wong, D M Pariser, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 30, 2019
Incidence of serious gastrointestinal events among tildrakizumab-treated patients with psoriasis: Letter to the EditorM Gooderham, B E Elewski, D M Pariser, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 11, 2021
Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis: phase 3 open-label studyM G Lebwohl, L Stein Gold, K Papp, et al.
Archives of Dermatology|December 1, 1996
Calcipotriene ointment applied once a day for psoriasis: a double-blind, multicenter, placebo-controlled studyD M Pariser, R J Pariser, D Breneman, et al.
Journal of the American Academy of Dermatology|November 26, 1999
A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialisL H Kaminester, R J Pariser, D M Pariser, et al.
The British Journal of Dermatology|May 7, 2009
Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trialD Y M Leung, J M Hanifin, D M Pariser, et al.
Journal of Patient-Reported Outcomes|September 6, 2019
Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severityL M Nelson, D DiBenedetti, D M Pariser, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Journal of the American Academy of Dermatology|August 1, 1994
Double-blind comparison of itraconazole and placebo in the treatment of tinea corporis and tinea crurisD M Pariser, R J Pariser, G Ruoff, et al.
The British Journal of Dermatology|December 15, 2015
Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled studyD M Pariser, L F Eichenfield, M Bukhalo, et al.
Archives of Dermatology|August 1, 1976
Intravenous desensitization to mechlorethamine in patients with psoriasisD M Pariser, R C Childers, P Kechijian, et al.
The British Journal of Dermatology|November 17, 2006
Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow upE H Tschen, D S Wong, D M Pariser, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 30, 2019
Incidence of serious gastrointestinal events among tildrakizumab-treated patients with psoriasis: Letter to the EditorM Gooderham, B E Elewski, D M Pariser, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 11, 2021
Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis: phase 3 open-label studyM G Lebwohl, L Stein Gold, K Papp, et al.
Archives of Dermatology|December 1, 1996
Calcipotriene ointment applied once a day for psoriasis: a double-blind, multicenter, placebo-controlled studyD M Pariser, R J Pariser, D Breneman, et al.
Journal of the American Academy of Dermatology|November 26, 1999
A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialisL H Kaminester, R J Pariser, D M Pariser, et al.
The British Journal of Dermatology|May 7, 2009
Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trialD Y M Leung, J M Hanifin, D M Pariser, et al.
Journal of Patient-Reported Outcomes|September 6, 2019
Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severityL M Nelson, D DiBenedetti, D M Pariser, et al.
Pageof 6